Table of Contents
Arthritis
Volume 2015, Article ID 784825, 7 pages
http://dx.doi.org/10.1155/2015/784825
Research Article

Antibodies to Infliximab and Adalimumab in Patients with Rheumatoid Arthritis in Clinical Remission: A Cross-Sectional Study

1Department of Clinical Biochemistry, Copenhagen University Hospital at Køge, 4600 Køge, Denmark
2Department of Rheumatology, Copenhagen University Hospital at Køge, 4600 Køge, Denmark
3The Parker Institute, Department of Rheumatology, Copenhagen University Hospitals at Frederiksberg and Bispebjerg, 2000 Copenhagen F, Denmark
4Institute for Inflammation Research (IIR), Rigshospitalet University Hospital, 2100 Copenhagen, Denmark
5DANBIO registry, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, 2600 Glostrup, Denmark
6Department of Rheumatology, Copenhagen University Hospital Glostrup, 2600 Glostrup, Denmark
7Department of Rheumatology, Odense University Hospital, 5000 Odense, Denmark
8Department of Rheumatology, Copenhagen University Hospitals at Frederiksberg and Bispebjerg, 2000 Frederiksberg, Denmark
9Department of Rheumatology, Copenhagen University Hospital at Gentofte, 2900 Gentofte, Denmark
10Department of Rheumatology, Copenhagen University Hospital at Holbæk, 4300 Holbæk, Denmark

Received 22 December 2014; Accepted 30 January 2015

Academic Editor: Alejandro Balsa

Copyright © 2015 Grith P. Eng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Sumin Bian, Thomas Van Stappen, Filip Baert, Griet Compernolle, Els Brouwers, Sophie Tops, Annick de Vries, Theo Rispens, Jeroen Lammertyn, Séverine Vermeire, and Ann Gils, “Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays,” Journal of Pharmaceutical and Biomedical Analysis, 2016. View at Publisher · View at Google Scholar
  • Wenhan Wang, Yaoge Liu, Xiaokai Wang, Weiwei Li, Yunpeng Zhao, Zhong Li, Qingjuan Meng, Pei Zhang, Pengcheng Yan, Zhenbiao Zhang, Hao Zhang, Jingrui Pan, and Yujia Zhai, “Chronic Calcium Channel Inhibitor Verapamil Antagonizes TNF-α-Mediated Inflammatory Reaction and Protects Against Inflammatory Arthritis in Mice.,” Inflammation, vol. 39, no. 5, pp. 1624–34, 2016. View at Publisher · View at Google Scholar
  • Vibeke Strand, Alejandro Balsa, Jamal Al-Saleh, Leonor Barile-Fabris, Takahiko Horiuchi, Tsutomu Takeuchi, Sadiq Lula, Charles Hawes, Blerina Kola, and Lisa Marshall, “Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review,” BioDrugs, 2017. View at Publisher · View at Google Scholar
  • Manca Ogrič, Matic Terčelj, Sonja Praprotnik, Matija Tomšič, Borut Božič, Snezna Sodin-Semrl, and Saša Čučnik, “Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits,” Immunologic Research, vol. 65, no. 1, pp. 172–185, 2017. View at Publisher · View at Google Scholar
  • Heidi S Schultz, Stine Louise Reedtz-Runge, B Thomas Bäckström, Kasper Lamberth, Christian R Pedersen, and Anne M Kvarnhammar, “Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay.,” PloS one, vol. 12, no. 5, 2017. View at Publisher · View at Google Scholar
  • A. M. Lila, V. I. Mazurov, E. V. Zonova, O. B. Nesmeyanova, T. V. Plaksina, D. G. Krechikova, O. V. Reshet’ko, L. N. Denisov, I. G. Gordeev, T. G. Pokrovskaya, O. V. Antipova, T. V. Kropotina, T. V. Povarova, P. A. Shesternya, E. N. Ushakova, N. F. Soroka, E. V. Kunder, A. V. Eremeeva, E. V. Chernyaeva, R. A. Ivanov, and P. S. Pukhtinskaya, “Comparative Evaluation Of The Long-Term Efficacy And Safety Of The Infliximab Biosimilar Bcd-055 And Reference Infliximab In Patients With Ankylosing Spondylitis: Results Of The International Multicenter Randomized Double-Blind Phase Iii Clinical Study Asart-2,” Rheumatology Science and Practice, vol. 56, no. 3, pp. 293–301, 2018. View at Publisher · View at Google Scholar
  • B. Gorovits, D. J. Baltrukonis, I. Bhattacharya, M. A. Birchler, D. Finco, D. Sikkema, M. S. Vincent, S. Lula, L. Marshall, and T. P. Hickling, “Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab,” Clinical & Experimental Immunology, 2018. View at Publisher · View at Google Scholar